- Home
- MTC vs ICU Comparison
MTC vs ICU Comparison
Compare MTC & ICU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTC
- ICU
- Stock Information
- Founded
- MTC 2015
- ICU 2018
- Country
- MTC Hong Kong
- ICU United States
- Employees
- MTC N/A
- ICU N/A
- Industry
- MTC Computer Software: Prepackaged Software
- ICU Biotechnology: Pharmaceutical Preparations
- Sector
- MTC Technology
- ICU Health Care
- Exchange
- MTC Nasdaq
- ICU Nasdaq
- Market Cap
- MTC 26.4M
- ICU 25.6M
- IPO Year
- MTC 2019
- ICU N/A
- Fundamental
- Price
- MTC $0.93
- ICU $0.79
- Analyst Decision
- MTC
- ICU
- Analyst Count
- MTC 0
- ICU 0
- Target Price
- MTC N/A
- ICU N/A
- AVG Volume (30 Days)
- MTC 70.6K
- ICU 1.4M
- Earning Date
- MTC 09-12-2025
- ICU 08-13-2025
- Dividend Yield
- MTC N/A
- ICU N/A
- EPS Growth
- MTC N/A
- ICU N/A
- EPS
- MTC N/A
- ICU N/A
- Revenue
- MTC $1,868,333.00
- ICU $766,000.00
- Revenue This Year
- MTC N/A
- ICU $894.81
- Revenue Next Year
- MTC N/A
- ICU $71.78
- P/E Ratio
- MTC N/A
- ICU N/A
- Revenue Growth
- MTC N/A
- ICU N/A
- 52 Week Low
- MTC $0.76
- ICU $0.31
- 52 Week High
- MTC $6.42
- ICU $5.79
- Technical
- Relative Strength Index (RSI)
- MTC 47.18
- ICU 48.18
- Support Level
- MTC $0.91
- ICU $0.81
- Resistance Level
- MTC $1.00
- ICU $0.92
- Average True Range (ATR)
- MTC 0.06
- ICU 0.07
- MACD
- MTC -0.00
- ICU -0.00
- Stochastic Oscillator
- MTC 32.02
- ICU 20.11
About MTC MMTec Inc.
MMTEC Inc provides Internet-based technology services and solutions to the Chinese language speaking hedge funds, mutual funds, registered investment advisors, proprietary trading groups, and brokerage firms engaging in securities market transactions and settlements globally. It offers complete suite trading solutions, including services such as fund establishment, issuance, custody, transaction, and settlement. The Company currently has two operating segments, Gujia, MM Future, HC Securities, and MM Global. It generates maximum revenue from the Gujia segment. Gujia segment provides market data services and investor relations management services to customers in China.
About ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.